Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Hingham Institution for Saving
HIFS
$690M
| $811K | ﹤0.01% |
4,171
+61
| +1% | +$10.5K |
|
2902
Aura Biosciences
AURA
$804M
| $810K | ﹤0.01% |
91,448
+18,725
| +26% | +$159K |
|
2903
NWPX Infrastructure Inc
NWPX
$1.09B
| $807K | ﹤0.01% |
26,663
-996
| -4% | -$28K |
|
2904
Jakks Pacific
JAKK
$288M
| $806K | ﹤0.01% |
22,665
+3,946
| +21% | +$102K |
|
2905
Orange County Bancorp
OBT
$522M
| $804K | ﹤0.01% |
26,678
| – | – |
|
|
TAST
2906
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $802K | ﹤0.01% |
101,812
-3,511
| -3% | -$23.9K |
|
2907
PMV Pharmaceuticals
PMVP
$66.7M
| $801K | ﹤0.01% |
258,527
-11,070
| -4% | -$29.3K |
|
2908
Hooker Furnishings Corp
HOFT
$160M
| $801K | ﹤0.01% |
30,703
| – | – |
|
|
MCBC
2909
DELISTED
Macatawa Bank Corp
MCBC
| $800K | ﹤0.01% |
70,942
-2,708
| -4% | -$26.5K |
|
|
PSTL
2910
Postal Realty Trust
PSTL
$701M
| $800K | ﹤0.01% |
54,956
+3,884
| +8% | +$54.1K |
|
|
VTYX
2911
DELISTED
Ventyx Biosciences
VTYX
| $798K | ﹤0.01% |
323,190
-40,195
| -11% | -$382K |
|
2912
Pangaea Logistics
PANL
$477M
| $796K | ﹤0.01% |
96,572
| – | – |
|
2913
Spok Holdings
SPOK
$230M
| $787K | ﹤0.01% |
50,864
-1,464
| -3% | -$22.5K |
|
2914
Alta Equipment Group
ALTG
$255M
| $785K | ﹤0.01% |
63,429
| – | – |
|
|
IAUX
2915
i-80 Gold Corp
IAUX
$1.52B
| $782K | ﹤0.01% |
444,218
+2,552
| +0.6% | +$3.92K |
|
|
TARO
2916
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $781K | ﹤0.01% |
18,686
-8
| -0% | -$295 |
|
2917
Vermilion Energy
VET
$1.73B
| $777K | ﹤0.01% |
64,427
+4,081
| +7% | +$54K |
|
|
TUYA
2918
Tuya Inc
TUYA
$1.09B
| $769K | ﹤0.01% |
334,386
-6,039
| -2% | -$11.2K |
|
|
GNTY
2919
DELISTED
Guaranty Bancshares
GNTY
| $768K | ﹤0.01% |
22,855
| – | – |
|
2920
Takeda Pharmaceutical
TAK
$55.6B
| $763K | ﹤0.01% |
53,444
-18,337
| -26% | -$260K |
|
2921
Prudential
PUK
$34.2B
| $761K | ﹤0.01% |
33,913
+18,172
| +115% | +$398K |
|
2922
Southern First Bancshares
SFST
$607M
| $761K | ﹤0.01% |
20,510
| – | – |
|
2923
Civista Bancshares
CIVB
$597M
| $759K | ﹤0.01% |
41,185
-1,553
| -4% | -$24.9K |
|
2924
STMicroelectronics
STM
$48.3B
| $758K | ﹤0.01% |
15,116
+4,001
| +36% | +$179K |
|
|
REFI
2925
Chicago Atlantic Real Estate Finance
REFI
$268M
| $757K | ﹤0.01% |
46,792
-1,716
| -4% | -$26.2K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.